Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges

M.K. Dishop, C. Langston

Source: Eur Respir Mon; 2007: 39: 21–36

Journal Issue: Pathology of the Lung

Disease area: Interstitial lung diseases, Paediatric lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M.K. Dishop, C. Langston. Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges. Eur Respir Mon; 2007: 39: 21–36

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology Source: Eur Respir Rev 2013; 22: 117-123 Year: 2013
Genetics of fibrosing lung diseases Source: Eur Respir J 2005; 25: 915-927 Year: 2005
Morphologic evaluation of lung in a scleroderma-like rabbit model Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006
Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019
Interstital lung diseases: update 2005 Source: Annual Congress 2005 - Clinical year in review Year: 2005
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016
Neuroendocrine cell hyperplasia in children with idiopathic interstitial pneumonia Source: International Congress 2015 – Interstitial lung diseases II Year: 2015
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021
Rare interstitial lung diseases of environmental origin Source: Eur Respir Mon 2011; 54: 301-316 Year: 2011
Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group Source: Eur Respir J 2005; 26: Suppl. 49, 500s Year: 2005
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016
Smoking-related interstitial lung diseases: a concise review Source: Eur Respir J 2001; 17: 122-132 Year: 2001
Interstitial lung diseases in infants and children Source: Eur Respir J 2008; 31: 658-666 Year: 2008
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009
Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015
Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015
An integrated approach in the diagnosis of smoking-related interstitial lung diseases Source: Eur Respir Rev 2012 21:207-217 Year: 2012